Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 6
2015 170
2016 293
2017 369
2018 405
2019 393
2020 482
2021 550
2022 472
2023 374
2024 310
2025 269
2026 57

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Cited In for PMID: 25428505

3,822 results

Results by year

Filters applied: . Clear all
Page 1
PD-1 blockade induces responses by inhibiting adaptive immune resistance.
Tumeh PC, Harview CL, Yearley JH, Shintaku IP, Taylor EJ, Robert L, Chmielowski B, Spasic M, Henry G, Ciobanu V, West AN, Carmona M, Kivork C, Seja E, Cherry G, Gutierrez AJ, Grogan TR, Mateus C, Tomasic G, Glaspy JA, Emerson RO, Robins H, Pierce RH, Elashoff DA, Robert C, Ribas A. Tumeh PC, et al. Nature. 2014 Nov 27;515(7528):568-71. doi: 10.1038/nature13954. Nature. 2014. PMID: 25428505 Free PMC article. Clinical Trial.
Adaptive resistance in cancer immunotherapy.
Yang K, Yang C, Xiong K, Hao J, Ye L. Yang K, et al. Cell Mol Immunol. 2026 May 20. doi: 10.1038/s41423-026-01424-9. Online ahead of print. Cell Mol Immunol. 2026. PMID: 42162306 Review.
Safety and efficacy of intratumoural anti-CTLA4 with intravenous anti-PD1.
Tselikas L, Susini S, Texier M, Yurchenko A, Routier E, Amini-Adle M, Tihic E, Mouraud S, Danlos FX, Ammari S, Raoult T, Roy S, Bredel D, Farhane S, Cassard L, Molinaro I, Eggermont A, Soria JC, Zitvogel L, Massard C, Paci A, de Baere T, Scoazec JY, Chaput N, Nikolaev S, Meyer N, Lebbé C, Dalle S, Robert C, Marabelle A. Tselikas L, et al. Nature. 2026 Apr 29. doi: 10.1038/s41586-026-10341-w. Online ahead of print. Nature. 2026. PMID: 42056527
Immune classification of advanced melanoma identifies non-responders to anti-PD1 therapy.
Gámez-Pozo A, Trilla-Fuertes L, Becerril-Gómez F, Lalanda-Delgado P, Soriano V, Garicano Goldaraz F, Lecumberri MJ, Rodríguez de la Borbolla M, Majem M, Pérez-Ruiz E, González-Cao M, Oramas J, López-Vacas R, Magdaleno A, Fra J, Martín-Carnicero A, Corral M, Puértolas T, Ramos-Ruiz R, Espinosa E, Fresno Vara JÁ. Gámez-Pozo A, et al. Cancer Immunol Immunother. 2026 Apr 28;75(5):156. doi: 10.1007/s00262-026-04392-1. Cancer Immunol Immunother. 2026. PMID: 42047827 Free PMC article.
3,822 results